Sitagliptin With Pembro in RCC and Melanoma

NCT07634380 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Advanced Renal Cell Carcinoma
Advanced Melanoma

Interventions

DRUG: Sitagliptin
DRUG: Pembrolizumab

Sponsor

Fernando Maciel Barbosa